Global Multiple Myeloma Drugs Market Professional Survey Report 2018
- QYR2458950
- 105 Pages
- February 2018
- Pharmaceuticals
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Novartis
Bristol-Myers Squibb Company
Takeda Oncology
Johnson & Johnson
Celgene Corporation
Apotex
Emcure Pharmaceuticals
Amgen
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Melphalan
Carmustine
Cyclophosphamide
Daratumumab
Doxorubicin Hydrochloride Liposome
Elotuzumab
Panobinostat
Other medication
By Application, the market can be split into
applicaton 1
applicaton 2
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Multiple Myeloma Drugs Market Professional Survey Report 2017
1 Industry Overview of Multiple Myeloma Drugs
1.1 Definition and Specifications of Multiple Myeloma Drugs
1.1.1 Definition of Multiple Myeloma Drugs
1.1.2 Specifications of Multiple Myeloma Drugs
1.2 Classification of Multiple Myeloma Drugs
1.2.1 Melphalan
1.2.2 Carmustine
1.2.3 Cyclophosphamide
1.2.4 Daratumumab
1.2.5 Doxorubicin Hydrochloride Liposome
1.2.6 Elotuzumab
1.2.7 Panobinostat
1.2.8 Other medication
1.3 Applications of Multiple Myeloma Drugs
1.3.1 applicaton 1
1.3.2 applicaton 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs
2.3 Manufacturing Process Analysis of Multiple Myeloma Drugs
2.4 Industry Chain Structure of Multiple Myeloma Drugs
3 Technical Data and Manufacturing Plants Analysis of Multiple Myeloma Drugs
3.1 Capacity and Commercial Production Date of Global Multiple Myeloma Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Multiple Myeloma Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Multiple Myeloma Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Multiple Myeloma Drugs Major Manufacturers in 2016
4 Global Multiple Myeloma Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Multiple Myeloma Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Multiple Myeloma Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Multiple Myeloma Drugs Sales and Growth Rate Analysis
4.3.2 2016 Multiple Myeloma Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Multiple Myeloma Drugs Sales Price
4.4.2 2016 Multiple Myeloma Drugs Sales Price Analysis (Company Segment)
5 Multiple Myeloma Drugs Regional Market Analysis
5.1 North America Multiple Myeloma Drugs Market Analysis
5.1.1 North America Multiple Myeloma Drugs Market Overview
5.1.2 North America 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.1.4 North America 2016 Multiple Myeloma Drugs Market Share Analysis
5.2 China Multiple Myeloma Drugs Market Analysis
5.2.1 China Multiple Myeloma Drugs Market Overview
5.2.2 China 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.2.4 China 2016 Multiple Myeloma Drugs Market Share Analysis
5.3 Europe Multiple Myeloma Drugs Market Analysis
5.3.1 Europe Multiple Myeloma Drugs Market Overview
5.3.2 Europe 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.3.4 Europe 2016 Multiple Myeloma Drugs Market Share Analysis
5.4 Southeast Asia Multiple Myeloma Drugs Market Analysis
5.4.1 Southeast Asia Multiple Myeloma Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Multiple Myeloma Drugs Market Share Analysis
5.5 Japan Multiple Myeloma Drugs Market Analysis
5.5.1 Japan Multiple Myeloma Drugs Market Overview
5.5.2 Japan 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.5.4 Japan 2016 Multiple Myeloma Drugs Market Share Analysis
5.6 India Multiple Myeloma Drugs Market Analysis
5.6.1 India Multiple Myeloma Drugs Market Overview
5.6.2 India 2012-2017E Multiple Myeloma Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Multiple Myeloma Drugs Sales Price Analysis
5.6.4 India 2016 Multiple Myeloma Drugs Market Share Analysis
6 Global 2012-2017E Multiple Myeloma Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Multiple Myeloma Drugs Sales by Type
6.2 Different Types of Multiple Myeloma Drugs Product Interview Price Analysis
6.3 Different Types of Multiple Myeloma Drugs Product Driving Factors Analysis
6.3.1 Melphalan of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.2 Carmustine of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.3 Cyclophosphamide of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.4 Daratumumab of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.5 Doxorubicin Hydrochloride Liposome of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.6 Elotuzumab of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.7 Panobinostat of Multiple Myeloma Drugs Growth Driving Factor Analysis
6.3.8 Other medication of Multiple Myeloma Drugs Growth Driving Factor Analysis
7 Global 2012-2017E Multiple Myeloma Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Multiple Myeloma Drugs Consumption by Application
7.2 Different Application of Multiple Myeloma Drugs Product Interview Price Analysis
7.3 Different Application of Multiple Myeloma Drugs Product Driving Factors Analysis
7.3.1 applicaton 1 of Multiple Myeloma Drugs Growth Driving Factor Analysis
7.3.2 applicaton 2 of Multiple Myeloma Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Multiple Myeloma Drugs
8.1 Novartis
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Novartis 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novartis 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Bristol-Myers Squibb Company 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Bristol-Myers Squibb Company 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.3 Takeda Oncology
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Takeda Oncology 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Takeda Oncology 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.4 Johnson & Johnson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Johnson & Johnson 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Johnson & Johnson 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.5 Celgene Corporation
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Celgene Corporation 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Celgene Corporation 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.6 Apotex
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Apotex 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Apotex 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.7 Emcure Pharmaceuticals
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Emcure Pharmaceuticals 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Emcure Pharmaceuticals 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
8.8 Amgen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Amgen 2016 Multiple Myeloma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Amgen 2016 Multiple Myeloma Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Multiple Myeloma Drugs Market
9.1 Global Multiple Myeloma Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Multiple Myeloma Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Multiple Myeloma Drugs Sales Price Forecast
9.2 Multiple Myeloma Drugs Regional Market Trend
9.2.1 North America 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.2.2 China 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.2.6 India 2017-2022 Multiple Myeloma Drugs Consumption Forecast
9.3 Multiple Myeloma Drugs Market Trend (Product Type)
9.4 Multiple Myeloma Drugs Market Trend (Application)
10 Multiple Myeloma Drugs Marketing Type Analysis
10.1 Multiple Myeloma Drugs Regional Marketing Type Analysis
10.2 Multiple Myeloma Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Multiple Myeloma Drugs by Region
10.4 Multiple Myeloma Drugs Supply Chain Analysis
11 Consumers Analysis of Multiple Myeloma Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Multiple Myeloma Drugs Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Multiple Myeloma Drugs
Table Product Specifications of Multiple Myeloma Drugs
Table Classification of Multiple Myeloma Drugs
Figure Global Production Market Share of Multiple Myeloma Drugs by Type in 2016
Figure Melphalan Picture
Table Major Manufacturers of Melphalan
Figure Carmustine Picture
Table Major Manufacturers of Carmustine
Figure Cyclophosphamide Picture
Table Major Manufacturers of Cyclophosphamide
Figure Daratumumab Picture
Table Major Manufacturers of Daratumumab
Figure Doxorubicin Hydrochloride Liposome Picture
Table Major Manufacturers of Doxorubicin Hydrochloride Liposome
Figure Elotuzumab Picture
Table Major Manufacturers of Elotuzumab
Figure Panobinostat Picture
Table Major Manufacturers of Panobinostat
Figure Other medication Picture
Table Major Manufacturers of Other medication
Table Applications of Multiple Myeloma Drugs
Figure Global Consumption Volume Market Share of Multiple Myeloma Drugs by Application in 2016
Figure applicaton 1 Examples
Table Major Consumers in applicaton 1
Figure applicaton 2 Examples
Table Major Consumers in applicaton 2
Figure Market Share of Multiple Myeloma Drugs by Regions
Figure North America Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Figure China Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Figure Europe Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Figure Japan Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Figure India Multiple Myeloma Drugs Market Size (Million USD) (2012-2022)
Table Multiple Myeloma Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Multiple Myeloma Drugs in 2016
Figure Manufacturing Process Analysis of Multiple Myeloma Drugs
Figure Industry Chain Structure of Multiple Myeloma Drugs
Table Capacity and Commercial Production Date of Global Multiple Myeloma Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Multiple Myeloma Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Multiple Myeloma Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Multiple Myeloma Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Multiple Myeloma Drugs 2012-2017
Figure Global 2012-2017E Multiple Myeloma Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Multiple Myeloma Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Multiple Myeloma Drugs Capacity and Growth Rate
Table 2016 Global Multiple Myeloma Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Multiple Myeloma Drugs Sales (K Units) and Growth Rate
Table 2016 Global Multiple Myeloma Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Multiple Myeloma Drugs Sales Price (USD/Unit)
Table 2016 Global Multiple Myeloma Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure North America 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure North America 2016 Multiple Myeloma Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure China 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure China 2016 Multiple Myeloma Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure Europe 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure Europe 2016 Multiple Myeloma Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Multiple Myeloma Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure Japan 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure Japan 2016 Multiple Myeloma Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Multiple Myeloma Drugs 2012-2017E
Figure India 2012-2017E Multiple Myeloma Drugs Sales Price (USD/Unit)
Figure India 2016 Multiple Myeloma Drugs Sales Market Share
Table Global 2012-2017E Multiple Myeloma Drugs Sales (K Units) by Type
Table Different Types Multiple Myeloma Drugs Product Interview Price
Table Global 2012-2017E Multiple Myeloma Drugs Sales (K Units) by Application
Table Different Application Multiple Myeloma Drugs Product Interview Price
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Multiple Myeloma Drugs Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bristol-Myers Squibb Company Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol-Myers Squibb Company Multiple Myeloma Drugs Business Region Distribution
Table Takeda Oncology Information List
Table Product A Overview
Table Product B Overview
Table 2015 Takeda Oncology Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Takeda Oncology Multiple Myeloma Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Multiple Myeloma Drugs Business Region Distribution
Table Celgene Corporation Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celgene Corporation Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Celgene Corporation Multiple Myeloma Drugs Business Region Distribution
Table Apotex Information List
Table Product A Overview
Table Product B Overview
Table 2016 Apotex Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Apotex Multiple Myeloma Drugs Business Region Distribution
Table Emcure Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Emcure Pharmaceuticals Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Emcure Pharmaceuticals Multiple Myeloma Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Multiple Myeloma Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Multiple Myeloma Drugs Business Region Distribution
Figure Global 2017-2022 Multiple Myeloma Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Multiple Myeloma Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Multiple Myeloma Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Multiple Myeloma Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Multiple Myeloma Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Multiple Myeloma Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Multiple Myeloma Drugs by Region
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
